(Q34595721)

3 August 2017

1 reference

title

Vascular effects of dietary L-arginine supplementation (English)

1 reference

3 August 2017

Robert B Preli

1

1 reference

3 August 2017

Karen Potvin Klein

series ordinal

2

1 reference

3 August 2017

David M Herrington

series ordinal

3

1 reference

3 August 2017

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

162

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

1-15

1 reference

Coronary stenosis dilatation induced by L-arginine

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Atherosclerosis and the two faces of endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

The L-arginine-nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Nitric oxide: an endogenous modulator of leukocyte adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Endogenous nitric oxide synthase inhibitors are responsible for the L -arginine paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

The clinical pharmacology of L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Cellular and molecular mechanisms of endothelial cell dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Discordant Effects of Dietary L-Arginine on Vascular Structure and Reactivity in Hypercholesterolemic Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Dietary l-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Dietary l-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Control of Accelerated Vein Graft Atheroma with the Nitric Oxide Precursor: l-Arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

L-arginine supplementation improves venous endothelial cell but not smooth muscle cell dysfunction induced by prolonged diet-induced hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Combination therapy of cholesterol reduction and L-arginine supplementation controls accelerated vein graft atheroma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit. Response according to treatment duration, anatomic site, and sex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

L-arginine supplementation in hypercholesterolemic rabbits normalizes leukocyte adhesion to non-endothelial matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Arginine needs, physiological state and usual diets. A reevaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Oral L-arginine in patients with coronary artery disease on medical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

Arginine intake and risk of coronary heart disease mortality in elderly men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900717-1

10.1016/S0021-9150(01)00717-1

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference